Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC)
OACC trades on Nasdaq in Finance, Blank Checks. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$10.75
0.00% on the day
Market cap
Blank-check company
Revenue
Blank-check company: no operating revenue
Net income
Blank-check company: no operating revenue
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | OACC on Nasdaq |
| Sector | Finance |
| Industry | Blank Checks |
| Country | United States |
| IPO year | 2024 |
| SEC CIK | 0002029769 |
| SEC industry code | Blank Checks |
| Incorporated in | E9 |
Financials
Blank-check company: no operating revenue.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B4 | 2024-10-24 |
| Latest annual report | 10-K | 2026-03-26 |
| Latest quarterly / interim | 10-Q | 2026-08-12 |
| Latest current report | 8-K | 2025-10-29 |
| Latest proxy | DEF 14A | 2026-10-02 |
Source: SEC EDGAR submissions feed, 60 recent filings. All filings on EDGAR.
Other listings for this company
| Ticker | Name | Price |
|---|---|---|
| OACCW | Oaktree Acquisition Corp. III Life Sciences Warrant | $1.00 |
Peers in Blank Checks
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| DMII | Drugs Made In America Acquisition II Corp. | $10.19 | 0.00% | $649.1M |
| GUAC | Berto Acquisition Corp. II | $9.91 | 0.00% | $390.3M |
| TACO | Berto Acquisition Corp. | $10.47 | +0.14% | $381.7M |
| PRE | Prenetics Global Limited Class A Ordinary Share | $21.27 | +0.52% | $360.3M |
| IRHO | Iron Horse Acquisitions II Corp. | $10.07 | +0.05% | $295.3M |
| FGII | FG Imperii Acquisition Corp. | $10.03 | +0.10% | $290.3M |
| APMC | AmperCap Acquisition Company | $9.96 | 0.00% | $198.8M |
| QRED | QuasarEdge Acquisition Corporation | $10.08 | +0.10% | $161.7M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier